Atherogenic lipoproteins in end-stage renal disease
- 1 October 2001
- journal article
- review article
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 38 (4), S30-S33
- https://doi.org/10.1053/ajkd.2001.27393
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Additive impacts of diabetes and renal failure on carotid atherosclerosisAtherosclerosis, 2000
- Role of hepatic lipase in intermediate-density lipoprotein and small, dense low-density lipoprotein formation in hemodialysis patientsKidney International, 1999
- Effect of simvastatin on the lipid profile of hemodialysis patientsKidney International, 1999
- Effects of the Nicotinic Acid Analogue Niceritrol on Lipoprotein Lp(a) and Coagulation-Fibrinolysis Status in Patients with Chronic Renal Failure on HemodialysisNephron, 1997
- Low-density lipoprotein particle size distribution in end-stage renal disease treated with hemodialysis or peritoneal dialysisAmerican Journal of Kidney Diseases, 1996
- High-resolution B-mode ultrasonography in evaluation of atherosclerosis in uremiaKidney International, 1995
- Hypertriglyceridemia and lowered apolipoprotein C-II/C-III ratio in uremia: Effect of a fibric acid, clinofibrateKidney International, 1993
- Impaired metabolism of high density lipoprotein in uremic patientsKidney International, 1992
- Aortic and large artery compliance in end-stage renal failureKidney International, 1990
- INTERMEDIATE-DENSITY LIPOPROTEINS AND PROGRESSION OF CORONARY ARTERY DISEASE IN HYPERCHOLESTEROLAEMIC MENThe Lancet, 1987